Advanced search
Publication Cover
Cancer Management and Research Volume 13, 2021 - Issue
Submit an article Journal homepage
111
Views
1
CrossRef citations to date
0
Altmetric
Original Research

Demographics, Changes in Treatment Patterns, and Outcomes of Bone and Soft Tissue Sarcomas in Korea—A Sarcoma-Specific, Institutional Registry-Based Analysis

Hyehyun Jeong1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Hyeon-Su Im1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea;2 Division of Hematology and Oncology, Ulsan University Hospital, Ulsan, Republic of Korea
,
Wanlim Kim3 Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Jong-Seok Lee3 Department of Orthopedic Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Si Yeol Song4 Department of Radiation Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Joon Seon Song5 Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Kyung-Ja Cho5 Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Hye Won Chung6 Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Min Hee Lee6 Department of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
,
Jeong Eun Kim1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of KoreaCorrespondence[email protected] [email protected]
&
Jin-Hee Ahn1 Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
 show all
Pages 8795-8802 | Published online: 24 Nov 2021

References

  • The WHO Classification of Tumors Editorial Board. WHO Classification of Tumours Soft Tissue and Bone Tumours. 5th ed. Lyon: IARC Press; 2020.
  • Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
  • Johnson AC, Ethun CG, Liu Y, et al. Studying a rare disease using multi-institutional research collaborations vs big data: where lies the truth? J Am Coll Surg. 2018;227(3):357–366 e353. doi:10.1016/j.jamcollsurg.2018.05.00929906615
  • Lloyd S, Park HS, Decker RH, Wilson LD, Yu JB. Using the surveillance, epidemiology, and end results database to investigate rare cancers, second malignancies, and trends in epidemiology, treatment, and outcomes. Curr Probl Cancer. 2012;36(4):191–199. doi:10.1016/j.currproblcancer.2012.03.00822495057
  • Lyu HG, Stein LA, Saadat LV, et al. Assessment of the accuracy of disease coding among patients diagnosed with sarcoma. JAMA Oncol. 2018;4(9):1293–1295. doi:10.1001/jamaoncol.2018.297930098150
  • Hess LM, Zhu YE, Sugihara T, Fang Y, Collins N, Nicol S. Challenges of using ICD-9-CM and ICD-10-CM codes for soft-tissue sarcoma in databases for health services research. Perspect Health Inf Manag. 2019;16:1a.
  • Brennan MF, Antonescu CR, Moraco N, Singer S. Lessons learned from the study of 10,000 patients with soft tissue sarcoma. Ann Surg. 2014;260(3):416–421; discussion 421–412. doi:10.1097/SLA.0000000000000869
  • Jorgensen PH, Lausten GS, Pedersen AB. The Danish sarcoma database. Clin Epidemiol. 2016;8:685–690. doi:10.2147/CLEP.S9949527822116
  • Raut CP, Miceli R, Strauss DC, et al. External validation of a multi-institutional retroperitoneal sarcoma nomogram. Cancer. 2016;122(9):1417–1424. doi:10.1002/cncr.2993126916507
  • Choi HJ, Lee MJ, Choi CM, et al. Establishing the role of honest broker: bridging the gap between protecting personal health data and clinical research efficiency. PeerJ. 2015;3:e1506. doi:10.7717/peerj.150626713253
  • Kim HS, Nam CM, Jang SY, et al. Characteristics and treatment patterns of patients with advanced soft tissue sarcoma in Korea. Cancer Res Treat. 2019;51(4):1380–1391. doi:10.4143/crt.2018.47630776883
  • Gadgeel SM, Harlan LC, Zeruto CA, Osswald M, Schwartz AG. Patterns of care in a population-based sample of soft tissue sarcoma patients in the United States. Cancer. 2009;115(12):2744–2754. doi:10.1002/cncr.2430719396819
  • Wang D, Abrams RA. Radiotherapy for soft tissue sarcoma: 50 years of change and improvement. Am Soc Clin Oncol Educ Book. 2014;244–251. doi:10.14694/EdBook_AM.2014.34.24424857082
  • Frustaci S, Gherlinzoni F, De Paoli A, et al. Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: results of the Italian randomized cooperative trial. J Clin Oncol. 2001;19(5):1238–1247. doi:10.1200/JCO.2001.19.5.123811230464
  • Le Cesne A, Ouali M, Leahy MG, et al. Doxorubicin-based adjuvant chemotherapy in soft tissue sarcoma: pooled analysis of two STBSG-EORTC Phase III clinical trials. Ann Oncol. 2014;25(12):2425–2432. doi:10.1093/annonc/mdu46025294887
  • Italiano A, Mathoulin-Pelissier S, Cesne AL, et al. Trends in survival for patients with metastatic soft-tissue sarcoma. Cancer. 2011;117(5):1049–1054. doi:10.1002/cncr.2553820945333
  • Kollar A, Rothermundt C, Klenke F, et al. Incidence, mortality, and survival trends of soft tissue and bone sarcoma in Switzerland between 1996 and 2015. Cancer Epidemiol. 2019;63:101596. doi:10.1016/j.canep.2019.10159631520938
  • Judson I, Verweij J, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled Phase 3 trial. Lancet Oncol. 2014;15(4):415–423. doi:10.1016/S1470-2045(14)70063-424618336
  • Recine F, Bongiovanni A, Riva N, et al. Update on the role of trabectedin in the treatment of intractable soft tissue sarcomas. Onco Targets Ther. 2017;10:1155–1164. doi:10.2147/OTT.S12795528260930
  • Hoven-Gondrie ML, Bastiaannet E, Ho VK, et al. Worse survival in elderly patients with extremity soft-tissue sarcoma. Ann Surg Oncol. 2016;23(8):2577–2585. doi:10.1245/s10434-016-5158-726957498
  • Lyu HG, Haider AH, Landman AB, Raut CP. The opportunities and shortcomings of using big data and national databases for sarcoma research. Cancer. 2019;125(17):2926–2934. doi:10.1002/cncr.3211831090929
  • Park HS, Lloyd S, Decker RH, Wilson LD, Yu JB. Limitations and biases of the surveillance, epidemiology, and end results database. Curr Probl Cancer. 2012;36(4):216–224. doi:10.1016/j.currproblcancer.2012.03.01122481009
  • REtroperitoneal SArcoma Registry: an international prospective initiative. Available from: https://ClinicalTrials.gov/show/NCT03838718. Accessed November 9, 2021.
  • GISAR German Interdisciplinary Sarcoma Registry. Available from: https://ClinicalTrials.gov/show/NCT04122872. Accessed November 9, 2021.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.